18 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/calliditas-provides-setanaxib-patent-update-302175403.html
16 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/in-person--virtual-rd-day-the-anti-fibrotic-effects-of-setanaxib-and-tarpeyos-mode-of-action-302147989.html
07 May 2024
// PHARMABIZ
06 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/calliditas-announces-positive-topline-results-of-phase-2-head-and-neck-cancer-trial-with-lead-nox-inhibitor-candidate-setanaxib-302136510.html
08 Apr 2024
// PHARMABIZ
08 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/calliditas-receives-notice-of-allowance-for-united-states-patent-application-covering-setanaxib-in-cancer-treatment-302110166.html
LOOKING FOR A SUPPLIER?